Concepedia

Sandra Hodnick

SH

Statistics

Publications

3

Citations

83

H-Index

3

Active since

2001

Affiliations

Cleveland Clinic(Current)

Sandra Hodnick is an author at Cleveland Clinic specializing in pharmacotherapy, medicine, and hepatology.

Top concepts

Publications per year

2001–2006

3

Publications

3

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy

Zobair M. Younossi, Kevin D. Mullen, Wisam Zakko et al. · Journal of Hepatology · 2001 · 47 citations

, , +9

Antitumor effects of sorafenib and sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC) who had prior therapy with anti-angiogenic agents

Ila Tamaskar, Philip Shaheen, L. Wood et al. · Journal of Clinical Oncology · 2006 · 25 citations

, , +16

Triple Combination of Interferon Alpha-2b, Ribavirin, and Amantadine for Treatment of Chronic Hepatitis C

Zobair M. Younossi, Kevin D. Mullen, Sandra Hodnick et al. · Journal of Clinical Gastroenterology · 2003 · 11 citations

, , +13

1–3 of 3